findmyKOL
Clinical trialNCT00409305CompletedPhase 2Interventional

The Effect of Betahistine on Body Weight in Obese Subjects

SponsorOBEcure Ltd.Enrollment280Obesity
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to examine the effect that betahistine has on body weight in obese subjects.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cahaba Research, Inc.

    Birmingham, Alabama, United States

  • Scripps Clinic, Nutrition Metabolic Research

    San Diego, California, United States

  • Diablo Clinical Research, Inc.

    Walnut Creek, California, United States

  • Miami Research Associates, Inc., Nutrition Division

    Miami, Florida, United States

  • Csra Partners in Health, Inc.

    Augusta, Georgia, United States

  • Nccr

    Chicago, Illinois, United States

  • Radiant Research, Inc.

    Chicago, Illinois, United States

  • American Health Network

    Indianapolis, Indiana, United States

  • Midwest Institute for Clinical Research

    Indianapolis, Indiana, United States

  • Radiant Research, Inc.

    Overland Park, Kansas, United States

  • L-Marc Research Center

    Louisville, Kentucky, United States

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana, United States

  • Radiant Research, Inc.

    Edina, Minnesota, United States

  • Diabetes & Endocrinology Specialists

    Chesterfield, Missouri, United States

  • Comprehensive Weight Control Program

    New York, New York, United States

  • Rochester Clinical Research, Inc.

    Rochester, New York, United States

  • Lindner Clinical Trial Center

    Cincinnati, Ohio, United States

  • Covance Cru, Inc.

    Portland, Oregon, United States

  • Diabetes & Glandular Disease Research Associates, Inc.

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Betahistine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2007
Primary completion
—
Completion
30 Jun 2007
Last update posted
21 Apr 2015
Registered enrollment
280
Registry id
NCT00409305

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.